Recombinant VP1 protein of norovirus GII.4 (Caliciviridae: <i>Norovirus</i>) is capable to induse the production of cross-reacting antibodies
Introduction. Norovirus (NoV) is one of the main causes of acute gastroenteritis. Currently, there is no vaccine to prevent norovirus infection. Vaccines under development are based on the capsid protein VP1, which is capable of forming virus-like particles. The aim of the work was to analyze the...
Saved in:
| Main Authors: | Vladislav A. Lapin, Dmitry V. Novikov, Alexander Yu. Kashnikov, Natalia V. Epifanova, Nadezhda A. Novikova, Ekaterina V. Mokhonova, Dmitry A. Melentev, Maria I. Tsyganova, Dmitry E. Zaitsev, Viktor V. Novikov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Central Research Institute for Epidemiology
2025-07-01
|
| Series: | Вопросы вирусологии |
| Subjects: | |
| Online Access: | https://virusjour.crie.ru/jour/article/viewFile/16753/989 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
by: Vladislav A. Lapin, et al.
Published: (2024-11-01) -
Immunological properties of a chimeric protein containing the major capsid protein of echovirus 30 (Picornaviridae: <i>Enterovirus: Enterovirus betacoxsackie</i>)
by: Dmitry A. Melentev, et al.
Published: (2025-04-01) -
Norovirus GII.4 antibodies in the Portuguese population
by: João Rodrigo Mesquita, et al.
Published: (2014-09-01) -
Detection of IgG antibody against the porcine norovirus GII.11 in human, domestic and wild animals
by: Jiayi Xu, et al.
Published: (2025-06-01) -
Features of the clinical course and approaches to the therapy of norovirus infection in children
by: R. V. Popova, et al.
Published: (2021-06-01)